Henric Bjorn Bjarke

Henric Bjorn Bjarke is COO & VP at Inozyme Pharma, Inc. (INZY). They have made 3 open-market trades across 2 companies since 2017, most recently 2022-12-15.

CIK 0001652179

Get an email the next time Henric Bjorn Bjarke files.Follow for free

2 open-market purchases totalling $130K since 2022, against 1 sale. Too few scored purchases to measure a record yet.

Current Position

Ticker	Shares	Value
INZY	105,441	$422K
OPHT	1,384	$2K
Total		$424K

Shares reported on the most recent Form 4, priced at the 2022-12-19 close.

Grade by Ticker

CINZY

1 trade

Get an email the next time Henric Bjorn Bjarke files

Free account. One email when the next filing comes in.

Follow Henric Bjorn Bjarke for free

Buy Track Record

Filings2

Only 2 discretionary filings — too few to score

Discretionary filings only. 10b5-1 plan trades, tax withholding and option exercises are excluded, and each column is one row per filing rather than per execution lot.

Sell Track Record

Filings1

No scored decision-sell filings

Decision sells only — a first sale after buying the stock, or a sale by a fund or 10% owner. Ordinary sales by officers and directors show no relationship to what the stock does next, so they are counted but not scored.

Volume by Type

POpen-Market Purchase

$130K

2 filings

AAward/Grant

$8K

1 filings

SOpen-Market Sale

$2K

1 filings

Companies

Trade History

3 total

INZYBUY

$30K

2022-12-157d: -22.8%

Buying the DipLarge Holdings IncreaseOpportunistic BuyDeep Dip Buy

INZYBUY

$100K

2022-04-197d: -11.6%

First-Time BuyerTop TradeMajor Holdings Increase (>50%)Opportunistic BuyDeep Dip Buy

•Increased holdings by 51%
•5 other insiders also purchased in last 30 days
+1 more

OPHTSELL

$2K

2017-01-057d: -7.8%

Top TradeOpportunistic SellExercise & Sell

Ticker	Type	Traded	Filed	Price	Value	7d Stock	30d Stock	90d Stock
INZY	BUY	2022-12-15	2022-12-19	$1.39	$30K	-22.8%	+25.7%	+102.9%
INZY	BUY	2022-04-19	2022-04-20	$3.69	$100K	-11.6%	-12.4%	+13.1%
OPHT	SELL	2017-01-05	2017-01-06	$4.96	$2K	-7.8%	-8.8%	-36.5%

Related Insiders

Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.